Insider sale
DYNE THERAPEUTICS, INC.
$8.37M
322.46K shares
What this filing means
ATLAS VENTURE OPPORTUNITY FUND I, L.P. plans to sell 322.46K shares of DYNE THERAPEUTICS, INC. valued at approximately $8.37M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/14/2026ACC: 0001628280-26-057191
10% Owner
Since Sep 2020
322.46K
Shares to sell
$8.37M
Approx. market value
322.46K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Private Placement
Cash
8/7/2020
322.46KTotal acquired322.46K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/7/2020 | Private Placement Cash | 322.46K | — |
| Total | 322.46K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
322.46K
Market value
$8.37M
8/14/2026
Total
Units
322.46K
Value
$8.37M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
8/14/2026 | 322.46K | $8.37M | Nasdaq | Planned |
| Total | 322.46K | $8.37M | ||